The cost of providing combined prevention and treatment services, including ART, to female sex workers in Burkina Faso

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Cianci, Fiona ^a   Sweeney, Sedona ^a   Konate, Issouf ^b   Nagot, Nicolas ^c   Low, Andrea ^c   Mayaud, Philippe ^a   Vickerman, Peter ^a,d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b CENTRE MURAZ   (Burkina Faso)

^c UNIV MONTPELLIER   (France)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ABACAVIR PLUS LAMIVUDINE PLUS LOPINAVIR PLUS RITONAVIR; ANTIRETROVIRUS AGENT; AVOCOMB; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; INDINAVIR; INDINAVIR PLUS LAMIVUDINE PLUS RITONAVIR PLUS ZIDOVUDINE; LAMIVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; LOPINAVIR; RITONAVIR; TENOFOVIR; UNCLASSIFIED DRUG; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; BURKINA FASO; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DRUG COST; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PATIENT MONITORING; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PROSTITUTION; PUBLIC HEALTH SERVICE; RETROSPECTIVE STUDY; TREATMENT DURATION; ECONOMICS; HIV INFECTIONS; OCCUPATIONAL EXPOSURE; STATISTICS AND NUMERICAL DATA; TIME;

ANTI-HIV AGENTS; BURKINA FASO; FEMALE; HEALTH CARE COSTS; HIV INFECTIONS; HUMANS; OCCUPATIONAL EXPOSURE; SEX WORKERS; TIME FACTORS;

EID: 84903388663     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100107     Document Type: Article

References (52)

1. UNAIDS (2011) 'World AIDS Day Report 2011'.
2. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. (2011) Prevention of HIV-1 Infection with Early Antiretroviral Therapy. New England Journal of Medicine 365: 493-505.
3. Modjarrad K, Chamot E, Vermund SH (2008) Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS 22: 2179-2185.
4. Jia Z, Mao Y, Zhang F, Ruan Y, Ma Y, et al. (2013) Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003?11): a national observational cohort study. The Lancet 382: 1195-1203.
5. Montague BT, Vuylsteke B, Buve A (2011) Sustainability of programs to reach high risk and marginalized populations living with HIV in resource limited settings: implications for HIV treatment and prevention. BMC Public Health 11: 701.
6. Granich RM, Gilks CF, Dye C, DeCock K, Williams BG (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. 373: 48-57.
7. National Institute of Drug Abuse (2012) The 2012 MTF survey.
8. Alary M, Lowndes CM (2004) The central role of clients of female sex workers in the dynamics of heterosexual HIV transmission in sub-Saharan Africa. AIDS 16: 945-947. (Pubitemid 38553716)
9. Baral S, Beyrer C, Muessig K, Poteat T, Wirtz AL, et al. (2012) Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis. The Lancet Infectious Diseases 12: 538-549.
10. Cote AM, Sobela F, Dzokoto A, Nzambi K, Asamoah-Adu C, et al. (2004) Transactional sex is the driving force in the dynamics of HIV in Accra, Ghana. AIDS 18: 917-925. (Pubitemid 38553712)
11. Vickerman P, Foss Am Fau - Pickles M, Pickles M Fau - Deering K, Deering K Fau - Verma S, Verma SFAUED, et al. (2010) To what extent is the HIV epidemic in southern India driven by commercial sex? A modelling analysis. AIDS 24: 2563-2572.
12. Alary M, Mukenge-Tshibaka L, Bernier F, Geraldo N, Lowndes CM, et al. (2003) Decline in the prevalence of HIV and sexually transmitted diseases among female sex workers in Cotonou, Benin, 1993-1999. AIDS 16: 463-470.
13. Lowndes CM, Alary M, Gnintoungbe CA, Bedard E, Mukenge L, et al. Management of sexually transmitted diseases and HIV prevention in men at high risk: targeting clients and non-paying sexual partners of female sex workers in Benin. AIDS 14: 2523-2534.
14. Fung IC, Guinness L, Vickerman P, Watts C, Vannela G, et al. (2007) Modelling the impact and cost-effectiveness of the HIV intervention programme amongst commercial sex workers in Ahmedabad, Gujarat, India. BMC Public Health 7: 195.
15. Vickerman P, Terris-Prestholt F, Delany S, Kumaranayake L, Rees H, et al. (2006) Are targeted HIV prevention activities cost-effective in high prevalence settings? Results from a sexually transmitted infection treatment project for sex workers in Johannesburg, South Africa. Sexually Transmitted Diseases 33.
16. Burgos JL, Gaebler JA, Strathdee SA, Lozada R, Staines H, et al. (2010) Cost-effectiveness of an intervention to reduce HIV/STI incidence and promote condom use among female sex workers in the Mexico-US border region. PLoS ONE [Electronic Resource] 5.
17. Prinja S, Bahuguna P, Rudra S, Gupta I, Kaur M, et al. (2011) Cost effectiveness of targeted HIV prevention interventions for female sex workers in India. Sex Transm Infect 87: 354-361.
18. Chandrashekar S, Vassall A Fau - Reddy B, Reddy B Fau - Shetty G, Shetty G Fau - Vickerman P, Vickerman P Fau - Alary M, et al. (2011) The costs of HIV prevention for different target populations in Mumbai, Thane and Bangalore. BMC Public Health 11: Suppl 6:S7.
19. WHO/UNAIDS/UNICEF (2011) Global HIV/AIDS Response: Epidemic update and health sector progress towards Universal Access 2011.
20. Chakrapani V, Newman PA, Shunmugam M, Kurian AK, Dubrow R (2009) Barriers to Free Antiretroviral Treatment Access for Female Sex Workers in Chennai, India. AIDS Patient Care STDS 23: 973-980.
21. UNICEF (2011) Burkina Faso statistics.
22. CNLS (2011) Enquete de surveillance comportementale aupres des groupes å haut risque: Travailleuse du sexe et leurs clients au Burkina Fso. Conseil National de Lutte Contre le Sida et les IST. pp. 146p.
23. Konate I, Traore I, Ouedraogo A, Sanon A, Diallo R, et al. (2011) Linking HIV Prevention and Care for Community Interventions Among High-Risk Women in Burkina Faso - The ARNS 1222 "Yerelon" Cohort. J Acquir Immune Defic Syndr 57: s50-s54.
24. Huet C, Ouedraogo A, Konate I, Traore I, Rouet F, et al. (2011) Long-term virological, immunological and mortality outcomes in a cohort of HIV-infected female sex workers treated with highly active antiretroviral therapy in Africa. BMC Public Health 11: 700.
25. Low AJ, Konate I Fau - Nagot N, Nagot N Fau - Weiss HA, Weiss Ha Fau - Kania D, Kania D Fau - Vickerman P, et al. (2014) Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study. J Acquir Immune Defic Syndr.
26. Creese A, Parker D, Kahn F (1994) Cost Analysis in Primary Health Care. United, N & Internat
27. BCEAO (2012) Taux d'interets de la BCEAO.
28. Halbwachs H (2000) 'Maintenance and the Life Expectancy of Healthcare Equipment in Developing Economies'. Health Estate Journal: pp26-23.
29. World Bank.
30. OANDA "Historical Exchange Rates".
31. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL (2005) Methods for the Economic Evaluation of Health Care Programmes: Oxford University Press.
32. Terris-Prestholt F, Santos A, Sweeney S, Kumaranayake L (2011) Guidelines for Cost Effectiveness Analysis of Syphilis Screening Strategies.
33. Yaya Bocum F KS, Sondo B (2009) Les caracteristiques des revenus des professionnels de la sante et leur relation avec la fourniture des soins au Burkina Faso Institut de Recherche en Science de la Sante.
34. WHO (2010) Antiretroviral therapy for HIV infection in Adults And Adolescents. Recommendations for a public health approach. WHO Library Cataloguing-in-Publication Data.
35. Jouquet G, Bygrave H, Kranzer Kea (2011) Cost and Cost-Effectiveness of Switching From d4T or AZT to a TDF-Based First-Line Regimen in a Resource-Limited Setting in Rural Lesotho. J Acquir Immune Defic Syndr 58: e68-e74.
36. Loubiere S, Meiners C, Sloan C, Freedberg KA, Yazdanpanah Y (2010) Economic evaluation of ART in resource-limited countries. Current Opinion in HIV & AIDS 5: 225-231.
37. Granich R, Kahn JG, Bennett R, Holmes CB, Garg N, et al. (2012) Expanding ART for Treatment and Prevention of HIV in South Africa: Estimated Cost and Cost-Effectiveness 2011-2050. PLoS ONE 7: e30216.
38. Chapko M, Liu C, Perkins M, Li Y, Fortney J, et al. (2009) Equivalence of two healthcare costing methods: bottom-up and top-down. Health Econ 18: 1188-1201.
39. S R, L L, M F, I S (2008) Cost and cost-effectiveness of switching from stavudine to tenofovir in first-line antiretroviral regimens in South Africa. J Acquir Immune Defic Syndr 48: 334-344.
40. Goldie SJ, Yazdanpanah Y, Losina E, Milton CW, Anglaret X, et al. (2006) Cost-effectiveness of HIV treat- ment in resource-poor settings: the case of Cote d'Ivoire. New England Journal of Medicine 355: 1141-1153. (Pubitemid 44394920)
41. Hogan DR, Baltussen R, Hayashi C, Lauer JA, Salomon JA (2005) Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. British Medical Journal 331: 1431-1437.
42. Rosen S, Long L, Sanne I (2008) The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa. Tropical Medicine & International Health 13: 1005-1015.
43. Hounton SH, Akonde A, Zannou DM, Bashi J, Meda N, et al. (2008) Costing universal access of highly active antiretroviral therapy in Benin. AIDS Care 20: 582-587.
44. UNAIDS UNAIDS country report.
45. Labor USDo CPI inflation calculator.
46. Harling G, Bekker LG, Wood R (2007) Cost of a dedicated ART clinic. S Afr Med J 97: 593-596. (Pubitemid 47412019)
47. Menzies NA, Berruti AA, Berzon R, Filler S, Ferris R, et al. (2011) The cost of providing comprehensive HIV treatment in PEPFAR-supported programs. AIDS 25: 1753-1760.
48. Jaffar S, Amuron B, Foster S, Birungi J, Levin J, et al. (2009) Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet 374: 2080-2089.
49. Bikilla AD, Jerene D, Robberstad B, Lindtjorn B (2009) Cost estimates of HIV care and treatment with and without anti-retroviral therapy at Arba Minch Hospital in southern Ethiopia. Cost Eff Resour Alloc 7: 6.
50. Deghaye N, Pawinski RA, Desmond C (2006) Financial and economic costs of scaling up the provision of HAART to HIV-infected health care workers in KwaZulu-Natal. South African Medical Journal Suid-Afrikaanse Tydskrif Vir Geneeskunde 96: 140-143. (Pubitemid 43263233)
51. Martinson N, Mohapi L, Bakos D, Gray GE, McIntyre JA, et al. (2009) Costs of Providing Care for HIV-Infected Adults in an Urban HIV Clinic in Soweto, South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes March 50: 327-330.
52. Tagar E SM, Condliffe K, Over M, Matatityo B, et al (2012) "Multi-Country Analysis of Treatment Costs for HIV/AIDS (MATCH): Unit costing at 161 Representative Facilities in Ethiopia, Malawi, Rwanda, South Africa and Zambia". New York: CHAI.